Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Eur Ann Allergy Clin Immunol ; 55(2): 78-85, 2023 03.
Article in English | MEDLINE | ID: mdl-35156357

ABSTRACT

Summary: Background. Anaphylaxis is a life-threatening hypersensitivity reaction. The present study aimed to investigate the cases of anaphylaxis to ant stings in Iran to determine the characteristics of patients, geographical distribution and the type of ants that cause anaphylaxis. Methods. Patients with a history of anaphylaxis to ant sting underwent skin allergy test with extracted substance from Solenopsis invicta. Samples of ants were collected from the sites where each patient was bitten and their species were identified by a medical entomologist. Results. Nineteen patients (mean age: 26.2 years; range: 4-48 years) were included in the study. Most patients (89.5 percent) were female. The lower limb was the most common site of the sting and most stings had occurred in the morning (31.6 %) and evening (31.6%). Skin manifestations were the most common clinical symptoms (94.7%). Most cases of stings were observed in the Hormozgan province (89.5%) located in southern Iran. Sixteen patients had positive skin prick test for ant venom. All collected ants that caused anaphylaxis belonged to the Pachycondyla sennaarensis species. Conclusions. Ant sting anaphylaxis is not uncommon in Iran, especially in its southern regions. All cases of anaphylaxis in this study were due to samsum ant sting (Pachycondyla sennaarensis), which is a species similar to the fire ant (Solenopsis invicta). Allergy skin testing with fire ant extract was positive and helpful in identifying samsum ant allergy in all cases.


Subject(s)
Anaphylaxis , Ant Venoms , Ants , Insect Bites and Stings , Animals , Humans , Female , Adult , Male , Anaphylaxis/diagnosis , Anaphylaxis/epidemiology , Anaphylaxis/etiology , Insect Bites and Stings/complications , Allergens
2.
Am J Physiol Regul Integr Comp Physiol ; 319(4): R412-R427, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32755465

ABSTRACT

In zebrafish (Danio rerio), a specific ionocyte subtype, the H+-ATPase-rich (HR) cell, is presumed to be a significant site of transepithelial Na+ uptake/acid secretion. During acclimation to environments differing in ionic composition or pH, ionic and acid-base regulations are achieved by adjustments to the activity level of HR cell ion transport proteins. In previous studies, the quantitative assessment of mRNA levels for genes involved in ionic and acid-base regulations relied on measurements using homogenates derived from the whole body (larvae) or the gill (adult). Such studies cannot distinguish whether any differences in gene expression arise from adjustments of ionocyte subtype numbers or transcriptional regulation specifically within individual ionocytes. The goal of the present study was to use fluorescence-activated cell sorting to separate the HR cells from other cellular subpopulations to facilitate the measurement of gene expression of HR cell-specific transporters and enzymes from larvae exposed to low pH (pH 4.0) or low Na+ (5 µM) conditions. The data demonstrate that treatment of larvae with acidic water for 4 days postfertilization caused cell-specific increases in H+-ATPase (atp6v1aa), ca17a, ca15a, nhe3b, and rhcgb mRNA in addition to increases in mRNA linked to cell proliferation. In fish exposed to low Na+, expression of nhe3b and rhcgb was increased owing to HR cell-specific regulation and elevated numbers of HR cells. Thus, the results of this study demonstrate that acclimation to low pH or low Na+ environmental conditions is facilitated by HR cell-specific transcriptional control and by HR cell proliferation.


Subject(s)
Ion Transport/genetics , Proton-Translocating ATPases/genetics , Sodium-Hydrogen Exchangers/genetics , Water , Zebrafish Proteins/genetics , Animals , Gills/metabolism , Hydrogen-Ion Concentration , Proton-Translocating ATPases/metabolism , Sodium/metabolism , Sodium-Hydrogen Exchangers/metabolism , Zebrafish , Zebrafish Proteins/metabolism
3.
J Invest Surg ; 32(8): 723-730, 2019 Dec.
Article in English | MEDLINE | ID: mdl-29693456

ABSTRACT

After gas chromatography and mass spectrometry of prepared methanolic extract of Allium sativum, 40 laboratory BALB/c mice were infected intraperitoneally by injection of 1,500 viable protoscoleces. Five months after infection, the infected mice were allocated into four treatment groups, including 1- Albendazole (100 mg/kg); 2- Allium sativum methanolic extract (10 mL/L); 3- A. sativum methanolic extract (10 mL/L) + Albendazole (50 mg /kg); and 4- untreated control group. After 30 days of daily treatment, total number and weight of cysts and size of the largest cyst as well as blood serum bilirubin and liver enzymes were compared between the mice of different groups.The total number and weight of cysts and size of the largest cyst were significantly lower in treated groups A. sativum 10 mL/L + Albendazole 50 and Albendazole 100 in comparison to those of the control group (p < 0.05).The activity of alanine aminotransferase (ALT) enzyme and bilirubin concentration were significantly lower in the mice treated with A. sativum 10 mL/L and A. sativum 10 mL/L + Albendazole 50, when compared to the control group. In addition, bilirubin concentration revealed significant decrease in A. sativum 10 mL/L and A. sativum 10 mL/L + Albendazole 50 groups, when compared to the Albendazole group. In conclusion, administration of A. sativum 10 mL/L improved the anti-hydatidosis activity of Albendazole 50 mg /kg, due to parasitological effects similar to Albendazole 100 mg /kg but less hepatotoxic effects.


Subject(s)
Albendazole/pharmacology , Anticestodal Agents/pharmacology , Echinococcosis/drug therapy , Echinococcus granulosus/drug effects , Garlic/chemistry , Plant Extracts/pharmacology , Administration, Oral , Albendazole/therapeutic use , Animals , Anticestodal Agents/therapeutic use , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination/methods , Echinococcosis/parasitology , Echinococcus granulosus/pathogenicity , Humans , Methanol/chemistry , Mice , Mice, Inbred BALB C , Plant Extracts/therapeutic use , Treatment Outcome
4.
Article in English | MEDLINE | ID: mdl-30396426

ABSTRACT

Plant-based anthelmintics suggest an alternative treatment for cystic echinococcosis. The present study was conducted to evaluate the efficacy of methanolic extract (ME) of A. sativum (garlic) on the treatment of hydatid cysts in the murine model. After gas chromatography and mass spectrometry of prepared ME, sixty laboratory BALB/c mice were infected intraperitoneally by injection of 1500 viable protoscoleces. Five months after infection, the infected mice were allocated into six treatment groups, 1- Albendazole (100 mg/kg); 2- Allium sativum ME (10 mL/L); 3- A. sativum ME (20 mL/L); 4- A. sativum ME (40 mL/L); 5- A. sativum ME (80 mL/L) and 6- untreated control group. After 30 days of daily treatment, the total number of cysts, size and weight of the largest cyst were significantly lower in three treated groups including A. sativum ME 80 mL/L, A. sativum ME 40 mL /L and albendazole in comparison to those of the control group (p < 0.05). The activity of alanine amino transferase (ALT) enzyme, as well as bilirubin concentration were significantly lower in the mice treated with A. sativum ME 80, 40, 20 and 10 mL/L when compared to the control group. In addition, bilirubin concentration revealed significant decrease in A. sativum ME 10, 20 and 80 mL/L groups, when compared to the albendazole group. In conclusions, administration of A. sativum ME used at 40 and 80 mL/L concentrations might be beneficial in the treatment of CE due to anti-parasitic effects similar to albendazole but less hepatotoxic effects.


Subject(s)
Anthelmintics/therapeutic use , Echinococcosis, Hepatic/drug therapy , Echinococcus granulosus/drug effects , Garlic/chemistry , Plant Extracts/pharmacology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Bilirubin/blood , CD13 Antigens/blood , Disease Models, Animal , Female , Gas Chromatography-Mass Spectrometry , Liver/drug effects , Mice , Mice, Inbred BALB C , Sheep , Sheep Diseases/parasitology
5.
Oral Dis ; 23(8): 1134-1143, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28675770

ABSTRACT

OBJECTIVE: To examine oral complications 6 months after modern radiation therapy (RT) for head and neck cancer (HNC). METHODS: Prospective multicenter cohort study of patients with HNC receiving intensity-modulated radiation therapy or more advanced RT. Stimulated whole salivary flow, maximal mouth opening, oral mucositis, oral pain, oral health-related quality of life (OH-QOL), and oral hygiene practices were measured in 372 subjects pre-RT and 216 subjects at 6 months from the start of RT. RESULTS: Mean stimulated whole salivary flow declined from 1.09 to 0.47 ml/min at 6 months (p < .0001). Mean maximal mouth opening reduced from 45.58 to 42.53 mm at 6 months (p < .0001). 8.1% of subjects had some oral mucositis at 6 months, including 3.8% with oral ulceration. Mean overall pain score was unchanged. OH-QOL was reduced at 6 months, with changes related to dry mouth, sticky saliva, swallowing solid foods, and sense of taste (p ≤ .0001). At 6 months, there was greater frequency of using dental floss and greater proportion using supplemental fluoride (p < .0001). CONCLUSIONS: Despite advances in RT techniques, patients with HNC experience oral complications 6 months after RT, with resulting negative impacts on oral function and quality of life.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Radiation Injuries/etiology , Radiotherapy, Intensity-Modulated/adverse effects , Saliva/radiation effects , Stomatitis/etiology , Aged , Female , Humans , Longitudinal Studies , Male , Middle Aged , Mouth/physiopathology , Mouth/radiation effects , Oral Hygiene , Pain/etiology , Prospective Studies , Quality of Life , Time Factors
6.
Radiat Prot Dosimetry ; 173(4): 333-337, 2017 Apr 15.
Article in English | MEDLINE | ID: mdl-26994097

ABSTRACT

In this research, the effect of magnesium (Mg) impurity on thermoluminescence (TL) response of ZrO2 phosphors is studied experimentally. In the experimental procedure, ZrO2:Mg phosphors in the powder form were synthesised by the sol-gel method. The obtained hydrogel was dried in air and then calcinated in air at 1200°C for 5 h and next was annealed at 250°C for 2 h. Sample characterisations were done by X-ray diffraction and scanning electron microscopy. Obtained materials had monoclinic phase and porous microstructure. Then, known amounts of ZrO2:Mg powder were exposed to ultraviolet lamp from 0.5 to 120 min. The TL peaks were obtained at the same temperature as 75, 137 and 260°C, respectively. Adding Mg to pure zirconia caused to increase TL intensity and shift peaks related to pure zirconia. The TL peaks of the pure zirconia were seen at the 83, 132 and 235°C. Finally, ZrO2:Mg TL experimental results show the linear dose response, high stability and less fading.


Subject(s)
Luminescent Measurements , Zirconium , Magnesium , Powders , Temperature , X-Ray Diffraction
7.
Niger J Clin Pract ; 19(5): 603-10, 2016.
Article in English | MEDLINE | ID: mdl-27538548

ABSTRACT

CONTEXT: Methadone maintenance is a standard treatment for opiate-dependent individuals. However, deficits in cognitive functioning have been associated with this treatment. AIM: This study aimed to determine the dose and treatment duration-related effects of methadone on executive functions. SETTING AND DESIGN: Pure male opioid users with no considerable history of other drug abuse, undergoing methadone maintenance treatment (MMT) were recruited from a major government-run de-addiction center. METHODS: Hot executive functions including decision-making and emotion recognition were assessed using the Iowa gambling task and Ekman faces test, whereas cold executive functions including working memory (WM), cognitive flexibility, and response inhibition were assessed using n-back, Wisconsin card sorting test, and the GO/NOGO task, respectively. Statistical Analyses Used: Descriptive statistics, Pearson's correlation coefficients, and multiple regression analysis were used to test the hypotheses of the study. RESULTS: Methadone dose and length of MMT were found to be associated with greater impairment in executive functions. Impairment in cognitive performance was also found to be inversely related to time since dosing. Regression analyses revealed that methadone dosage and time since dosing accounted for a significant proportion of the variance in cognitive flexibility, while the total amount of methadone administered was able to predict deficits in WM, methadone treatment duration predicted psychomotor speed, and time since dosing predicted decision-making ability. CONCLUSIONS: To keep cognitive impairment at a minimum, methadone dose and treatment duration will have to be customized considering the history of opiate abuse so that impairment attributable to long-term opiate use may be differentiated from acute methadone dosing.


Subject(s)
Executive Function/drug effects , Methadone , Opiate Substitution Treatment/methods , Decision Making/drug effects , Humans , Methadone/administration & dosage , Methadone/pharmacology , Methadone/therapeutic use
8.
East Mediterr Health J ; 16(9): 942-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21218720

ABSTRACT

The causes of blindness in Yemen were determined in people aged 50+ years in both a community- and hospital-based study and documented using WHO/PBL criteria. In the community sample of 707 individuals in a rural area of Taiz governorate the prevalence of bilateral blindness was 7.9% and the main causes were cataract (71.4%) and age-related macular degeneration (ARMD) (14.3%). Corneal opacities and uncorrected aphakia were rare (1 case each) and there were no cases of diabetic retinopathy. Unilateral blindness was found in 8.6% of the community sample. In a case-notes review of 1320 new patients attending an eye clinic in Sana'a, bilateral blindness was documented in 26.5% and unilateral blindness in 9.0% (main causes: cataract, glaucoma, ARMD, diabetic retinopathy, corneal opacities and trauma.


Subject(s)
Blindness , Patient Admission/statistics & numerical data , Suburban Health/statistics & numerical data , Urban Health/statistics & numerical data , Age Distribution , Aged , Blindness/epidemiology , Blindness/etiology , Cataract/complications , Cataract/epidemiology , Causality , Corneal Perforation/complications , Corneal Perforation/epidemiology , Cross-Sectional Studies , Female , Glaucoma/complications , Glaucoma/epidemiology , Humans , Macular Degeneration/complications , Macular Degeneration/epidemiology , Male , Middle Aged , Population Surveillance , Prevalence , Sex Distribution , Yemen/epidemiology
9.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-117984

ABSTRACT

The causes of blindness in Yemen were determined in people aged 50+ years in both a communityand hospital-based study and documented using WHO/PBL criteria. In the community sample of 707 individuals in a rural area of Taiz governorate the prevalence of bilateral blindness was 7.9% and the main causes were cataract [71.4%] and age-related macular degeneration [ARMD] [14.3%]. Corneal opacities and uncorrected aphakia were rare [1 case each] and there were no cases of diabetic retinopathy. Unilateral blindness was found in 8.6% of the community sample. In a case-notes review of 1320 new patients attending an eye clinic in Sana'a, bilateral blindness was documented in 26.5% and unilateral blindness in 9.0% [main causes: cataract, glaucoma, ARMD, diabetic retinopathy, corneal opacities and trauma


Subject(s)
Prevalence , Cataract , Glaucoma , Macular Degeneration , Corneal Opacity , Blindness
10.
J Biol Chem ; 276(45): 42050-6, 2001 Nov 09.
Article in English | MEDLINE | ID: mdl-11562372

ABSTRACT

We have shown before that Na(+)/K(+)-ATPase acts as a signal transducer, through protein-protein interactions, in addition to being an ion pump. Interaction of ouabain with the enzyme of the intact cells causes activation of Src, transactivation of EGFR, and activation of the Ras/ERK1/2 cascade. To determine the role of protein kinase C (PKC) in this pathway, neonatal rat cardiac myocytes were exposed to ouabain and assayed for translocation/activation of PKC from cytosolic to particulate fractions. Ouabain caused rapid and sustained stimulation of this translocation, evidenced by the assay of Ca(2+)-dependent and Ca(2+)-independent PKC activities and by the immunoblot analysis of the alpha, delta, and epsilon isoforms of PKC. Dose-dependent stimulation of PKC translocation by ouabain (1-100 microm) was accompanied by no more than 50% inhibition of Na(+)/K(+)-ATPase and doubling of [Ca(2+)](i), changes that do not affect myocyte viability and are known to be associated with positive inotropic, but not toxic, effects of ouabain in rat cardiac ventricles. Ouabain-induced activation of ERK1/2 was blocked by PKC inhibitors calphostin C and chelerythrine. An inhibitor of phosphoinositide turnover in myocytes also antagonized ouabain-induced PKC translocation and ERK1/2 activation. These and previous findings indicate that ouabain-induced activation of PKC and Ras, each linked to Na(+)/K(+)-ATPase through Src/EGFR, are both required for the activation of ERK1/2. Ouabain-induced PKC translocation and ERK1/2 activation were dependent on the presence of Ca(2+) in the medium, suggesting that the signal-transducing and ion-pumping functions of Na(+)/K(+)-ATPase cooperate in activation of these protein kinases and the resulting regulation of contractility and growth of the cardiac myocyte.


Subject(s)
Mitogen-Activated Protein Kinase 1/physiology , Mitogen-Activated Protein Kinases/physiology , Protein Kinase C/physiology , Sodium-Potassium-Exchanging ATPase/physiology , Animals , Calcium/metabolism , Enzyme Activation , Mitogen-Activated Protein Kinase 3 , Ouabain/pharmacology , Rats , Rats, Sprague-Dawley , Type C Phospholipases/physiology , ras Proteins/physiology
11.
Am J Physiol Regul Integr Comp Physiol ; 280(1): R274-81, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11124161

ABSTRACT

Norepinephrine (NE)-induced desensitization of the adrenergic receptor pathway may mimic the effects of hypoxia on cardiac adrenoceptors. The mechanisms involved in this desensitization were evaluated in male Wistar rats kept in a hypobaric chamber (380 Torr) and in rats infused with NE (0.3 mg. kg(-1). h(-1)) for 21 days. Because NE treatment resulted in left ventricular (LV) hypertrophy, whereas hypoxia resulted in right (RV) hypertrophy, the selective hypertrophic response of hypoxia and NE was also evaluated. In hypoxia, alpha(1)-adrenergic receptors (AR) density increased by 35%, only in the LV. In NE, alpha(1)-AR density decreased by 43% in the RV. Both hypoxia and NE decreased beta-AR density. No difference was found in receptor apparent affinity. Stimulated maximal activity of adenylate cyclase decreased in both ventricles with hypoxia (LV, 41%; RV, 36%) but only in LV with NE infusion (42%). The functional activities of G(i) and G(s) proteins in cardiac membranes were assessed by incubation with pertussis toxin (PT) and cholera toxin (CT). PT had an important effect in abolishing the decrease in isoproterenol-induced stimulation of adenylate cyclase in hypoxia; however, pretreatment of the NE ventricle cells with PT failed to restore this stimulation. Although CT attenuates the basal activity of adenylate cyclase in the RV and the isoproterenol-stimulated activity in the LV, pretreatment of NE or hypoxic cardiac membranes with CT has a less clear effect on the adenylate cyclase pathway. The present study has demonstrated that 1) NE does not mimic the effects of hypoxia at the cellular level, i.e., hypoxia has specific effects on cardiac adrenergic signaling, and 2) changes in alpha- and beta-adrenergic pathways are chamber specific and may depend on the type of stimulation (hypoxia or adrenergic).


Subject(s)
Hypoxia/metabolism , Norepinephrine/pharmacology , Receptors, Adrenergic, alpha-1/metabolism , Receptors, Adrenergic, beta/metabolism , Signal Transduction/physiology , Sympathomimetics/pharmacology , Adenylate Cyclase Toxin , Adenylyl Cyclases/metabolism , Adrenergic beta-Agonists/metabolism , Adrenergic beta-Agonists/pharmacology , Animals , Cholera Toxin/pharmacology , Chronic Disease , Colforsin/pharmacology , GTP-Binding Proteins/metabolism , Guanosine Triphosphate/pharmacology , Heart Rate , Heart Ventricles/enzymology , Heart Ventricles/innervation , Heart Ventricles/pathology , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Right Ventricular/metabolism , Isoproterenol/pharmacology , Male , Myocardium/enzymology , Myocardium/pathology , Pertussis Toxin , Propanolamines/metabolism , Propanolamines/pharmacology , Protein Kinase C/metabolism , Rats , Rats, Wistar , Signal Transduction/drug effects , Sodium Fluoride/pharmacology , Tritium , Virulence Factors, Bordetella/pharmacology , Weight Gain
12.
Biochem Pharmacol ; 54(2): 293-7, 1997 Jul 15.
Article in English | MEDLINE | ID: mdl-9271334

ABSTRACT

Fenspiride inhibits the calcium signal evoked by the inflammatory peptide formyl-Met-Leu-Phe (fMLP) in peritoneal macrophages, but at concentrations (approximately 1 mM) far above the therapeutic range (approximately 1 microM). Here, in rat alveolar macrophages, high fenspiride concentrations (1 mM) were required to inhibit the calcium signals evoked by the calcium agonist Bay K8644 or by ionomycin. Moreover, fenspiride (1 mM) was a poor inhibitor of the cell membrane depolarization induced by gramicidine D. By contrast, fenspiride blocked Na+-H+ antiport activation by (i) fMLP with an IC50 = 3.1 +/- 1.9 nM and (ii) PMA (phorbol 12-myristate 13-acetate) with an IC50 = 9.2 +/- 3.1 nM. Finally, protein kinase C (PKC) activity of macrophage homogenate was not significantly modified by 10 or 100 microM fenspiride (at 100 microM: 2.57 +/- 1.60 vs. 2.80 +/- 1.71 pmol/10(6) cells/min). In conclusion, fenspiride inhibits fMLP- and PMA-induced pH signals in rat alveolar macrophages, probably by acting distally on the PKC transduction signal. This pH antagonistic action may be relevant for the antiinflammatory mechanism of fenspiride and requires further investigation.


Subject(s)
Bronchodilator Agents/pharmacology , Macrophages, Alveolar/drug effects , Spiro Compounds/pharmacology , Animals , Calcium/metabolism , Cell Membrane/drug effects , Hydrogen-Ion Concentration , N-Formylmethionine Leucyl-Phenylalanine , Rats , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate
13.
J Mol Cell Cardiol ; 29(6): 1687-94, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9220354

ABSTRACT

Protein Kinase C (PKC) is implicated in the induction of myocardial hypertrophy. Recent studies showed an increased activity and expression of PKC in rat left ventricular hypertrophy, but we demonstrated a decreased PKC activity and content in rabbit heart failure. The present study was designed to evaluate whether these differences were due to species or model differences. PKC activity and expression were measured in a model of mild ventricular overload, induced by a 40-50% constriction of the abdominal aorta in rabbits. Left ventricular (LV) weight/body weight ratio was increased by 14, 21 and 36% after 4, 18 and 42 days of stenosis, respectively. PKC activity was significantly decreased after 18 and 42 days of stenosis in the particulate fraction of LV, but it was not modified in the cytosolic fraction leading to a significantly decreased translocation index (particulate/total activity ratio): 18.6 +/- 2.2% and 19.4 +/- 1.6% at 18 days and 42 days of aortic stenosis, respectively, compared with 25.7 +/- 2.0% and 25.8 +/- 1.2% in corresponding sham-operated rabbits (both Ps < 0.05). Similarly, PKC content, measured by immunoblotting, was not modified in the cytosolic fractions, but decreased significantly in the particulate fractions after 18 and 42 days of stenosis. These data are, thus, different from those obtained in rat LV hypertrophy showing species differences in PKC expression in hypertrophy. They also show that hypertrophy may take place without induction of PKC.


Subject(s)
Hypertrophy, Left Ventricular/enzymology , Protein Kinase C/metabolism , Animals , Aortic Valve Stenosis/enzymology , Blotting, Western , Disease Models, Animal , Female , Hemodynamics , Isoenzymes , Protein Kinase C/analysis , Rabbits , Species Specificity , Time Factors
14.
Circ Res ; 79(2): 153-61, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8755991

ABSTRACT

Protein kinase C (PKC) is activated by alpha-adrenergic stimulation. Molecular analysis showed that PKC consists of a family of at least 12 isozymes. Studies of their distribution in the heart showed conflicting results. The first goal of our study was thus to characterize cardiac PKC in normal rabbits. PKC plays an important role in gene expression, cell growth, and differentiation and is involved in the hypertrophy phase of cardiac overload, but since its expression has never been evaluated in heart failure, the second goal of our study was to evaluate PKC activity and isoform expression in rabbits with heart failure induced by a double hemodynamic overload (aortic insufficiency followed by an aortic stenosis). In the first part of the study, PKC isoform expression analyzed in normal rabbits by immunoblotting showed that isoforms alpha, beta, epsilon, and zeta were expressed along with PKC gamma, which had never been detected in the heart. PKC gamma expression was also identified by polymerase chain reaction, and immunofluorescence techniques showed a localization on intercalated disks associated with the membrane localization observed with the other isoforms. In the second part of the study, PKC activity, content, and isoform expression showed a decrease of 37% in the failing group. PKC immunodetection with a monoclonal antibody (Mab 1.9) recognizing the catalytic domain of all PKC isoforms revealed a 20% decrease in the failing ventricles compared with normal left ventricles. Expressed PKC isoforms quantified by Western blot showed, in the failing heart group compared with the control group, a decrease of 27%, 32%, 16%, and 9% of PKC alpha, PKC beta 1, PKC gamma, and PKC epsilon, respectively, whereas PKC zeta was not significantly modified. These results show that, in heart failure, PKC activity and expression of Ca(2+)-dependent PKC isoforms are decreased. This may lead to alterations of PKC-induced phosphorylations.


Subject(s)
Cardiac Output, Low/enzymology , Isoenzymes/metabolism , Protein Kinase C/metabolism , Amino Acid Sequence , Animals , Base Sequence , Fluorescent Antibody Technique, Indirect , Gene Amplification , Heart Ventricles , Immunoblotting , Immunohistochemistry , Isoenzymes/genetics , Molecular Probes/genetics , Molecular Sequence Data , Myocardium/enzymology , Protein Kinase C/genetics , Rabbits , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL